Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Short term Debt: 2023-2024

Historic Short term Debt for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $10.2 million.

  • Zhengye Biotechnology Holding's Short term Debt was N/A to $11.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $11.2 million, marking a year-over-year change of. This contributed to the annual value of $10.2 million for FY2024, which is 9.75% down from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Short term Debt of $10.2 million as of FY2024, which was down 9.75% from $11.3 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Short term Debt high stood at $11.3 million for FY2023, and its period low was $10.2 million during FY2024.
  • Its 2-year average for Short term Debt is $10.7 million, with a median of $10.7 million in 2024.
  • Data for Zhengye Biotechnology Holding's Short term Debt shows a maximum YoY dropped of 9.75% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Short term Debt (Yearly) stood at $11.3 million in 2023, then decreased by 9.75% to $10.2 million in 2024.